Trials / Completed
CompletedNCT07465146
Effects of Minimal and Metabolic Flow Sevoflurane Anesthesia in Gynecological Surgery Patients
Comparative Analysis of Sevoflurane-Based Minimal and Metabolic Flow Anaesthesia: A Prospective Randomized Study in a Gynecological Surgery Patient Cohort
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 97 (actual)
- Sponsor
- Baskent University · Academic / Other
- Sex
- Female
- Age
- 18 Years – 65 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to observe the effects of minimal and metabolically required basal anesthetic gas flow rates delivered by the anesthesia workstation under general anesthesia on body temperature, blood pressure, and heart rate during surgery. It also aims to evaluate the impact of reducing excessive delivery of anesthetic gases, air, and oxygen beyond the patient's physiological needs during general anesthesia on minimizing the harmful effects of anesthetic gases on the environment, climate, and global warming, as well as on contributing positively to hospital costs.
Detailed description
This prospective randomized study will be conducted in adult female patients undergoing elective gynecological surgery under general anesthesia. Following standard intravenous induction and endotracheal intubation, anesthesia will be maintained with sevoflurane using an advanced anesthesia workstation capable of delivering minimal and metabolic fresh gas flow rates. After achieving the target anesthetic depth guided by minimum alveolar concentration (MAC) and MAC Brain monitoring, patients will be randomized to receive either minimal-flow (0.5 L/min) or metabolic-flow (0.3 L/min) fresh gas anesthesia. Randomization will be performed using an internet-based randomization tool. Standard intraoperative monitoring will be applied in all patients, including electrocardiography, non-invasive blood pressure monitoring, pulse oximetry, capnography, anesthetic gas analysis, and esophageal temperature monitoring. Hemodynamic and respiratory parameters will be recorded at predefined time intervals throughout surgery. Sevoflurane consumption will be automatically calculated by the anesthesia workstation. At the end of surgery, fresh gas flow will be increased to eliminate residual anesthetic gases, and patients will be extubated according to standard clinical criteria. Postoperative monitoring will continue in the post-anesthesia care unit. The total study duration for each participant includes the intraoperative period and approximately 30 minutes of postoperative monitoring.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Low Flow Anesthesia | Adjustment of fresh gas flow rates during general anesthesia using a modern anesthesia workstation (Getinge Flow-C). Patients will be randomized to receive anesthesia with either minimal flow (0.5 L/min) or metabolic flow (0.3 L/min). All other anesthetic agents and monitoring parameters will remain standardized according to institutional protocols. |
Timeline
- Start date
- 2024-11-05
- Primary completion
- 2025-02-05
- Completion
- 2025-02-05
- First posted
- 2026-03-11
- Last updated
- 2026-03-11
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT07465146. Inclusion in this directory is not an endorsement.